Skip to main content
Back to Australian Medical School Compare
Australian Medical school comparison

Bond vs Tasmania

Bond and Tasmania are both Australian medical schools, but the path to an offer at each is meaningfully different. Bond is in Queensland while Tasmania is in Tasmania. State of origin matters here: several schools rank local applicants ahead of interstate ones. Bond uses Bond-Test; Tasmania uses UCAT-ANZ and GAMSAT.

That mismatch means either preparing two assessments or choosing the school whose test suits you. The interview formats diverge — Panel vs Interview — and the prep approaches for the two are fundamentally different.

Side-by-side comparison

Bond

Gold Coast

Quick comparison

Location
Gold Coast, Australia
Entry pathway
Undergraduate
Admission tests
Bond-Test
GAMSAT
-
UCAT-ANZ
-
ATAR
Undergraduate (Year 12): ATAR 96+ / IB 38+ / OP 1-3. Graduate: cumulative GPA ≥ 6.0/7.0 from recognised tertiary program.
Interview format
Bond psychometric assessment + Multiple Mini Interview (in person at Gold Coast)
Post-interview chance
~35% interview-to-offer.
Decision date
24-26 March 2026 (Round 1 offers); rolling intakes May + September (no February intake)

Tasmania

Hobart

Quick comparison

Location
Hobart, Australia
Entry pathway
Undergraduate
Admission tests
UCAT-ANZ + GAMSAT
GAMSAT
Graduate stream only: minimum 50 in each section.
UCAT-ANZ
No fixed domestic threshold; 2025 indicative cut-off ~2530/2700 (5th decile; Matrix Education). Competitive range observed 70th-85th percentile UCAT total. International applicants need ≥50th percentile cognitive subtests.
ATAR
Non-rural / non-Tasmanian: minimum 95, typical competitive 99.95. Rural or Tasmanian: minimum 95, typical competitive 99.45 (some sources 99.44). Flat since at least 2022.
Interview format
No interview — ATAR-first ranking with UCAT-ANZ tiebreaker
Post-interview chance
N/A — no interview.
Decision date
January

Bond vs Tasmania - in detail

Admission tests compared

UCAT-ANZ cut-offs. Bond — no published cut-off. Tasmania — No fixed domestic threshold; 2025 indicative cut-off ~2530/2700 (5th decile; Matrix Education). Competitive range observed 70th-85th percentile UCAT total. International applicants need ≥50th…

GAMSAT cut-offs. Bond — not used or not published. Tasmania — Graduate stream only: minimum 50 in each section.

Timing shapes the choice as much as the score. GAMSAT is graduate-only and sits in March and September; UCAT-ANZ is mostly undergraduate and sits in July. A few schools run their own selection model with no national test at all.

ATAR and academic profile

Bond requires Undergraduate (Year 12) ATAR 96+ / IB 38+ / OP 1-3, OR Graduate cumulative GPA ≥ 6.0/7.0 from recognised tertiary program. English (Units 3/4, C) or equivalent prerequisite. Bond psychometric test (~$346.50 inc. GST, 2025) + MMI in person at Gold Coast.

Lateral entry available from Bond BBiomedSci PHP / MOT / DPT / MNDP / MHI with GPA ≥ 3.00/4.00 (Bond scale) → Year 2 BMedSt.

Tasmania requires School-leaver ATAR minimum 95 (typical competitive non-rural 99.95; rural / Tasmanian 99.45) + UCAT-ANZ (no fixed threshold for domestic; international applicants need ≥50th percentile cognitive). Graduate stream: GAMSAT minimum 50 in each section + unweighted GPA ≥ 6.5. English and Chemistry prerequisites; no interview.

ATAR. Bond — Undergraduate (Year 12): ATAR 96+ / IB 38+ / OP 1-3. Graduate: cumulative GPA ≥ 6.0/7.0 from recognised tertiary program. Tasmania — Non-rural / non-Tasmanian: minimum 95, typical competitive 99.95. Rural or Tasmanian: minimum 95, typical competitive 99.45 (some sources 99.44). Flat since at least 2022.

Graduate-entry GPA. Bond — not applicable or not published. Tasmania — Graduate stream only: unweighted minimum 6.5.

Read every ATAR figure as a selection rank, not a raw score. Educational access bonuses, rural-origin uplift and Indigenous pathways all adjust it, so the published number is rarely the one that decides your application.

Interview formats

Bond uses Panel (Bond psychometric assessment + Multiple Mini Interview (in person at Gold Coast)); Tasmania uses Interview (No interview — ATAR-first ranking with UCAT-ANZ tiebreaker). These two formats reward different skills — Panel emphasises narrative coherence and the ability to develop a thread under follow-up questioning, while Interview rewards malleability and intellectual honesty.

If your strengths lie in conversational depth, Bond may suit you more. If you prefer discrete capsule answers under time pressure, either is the better fit.

Interview windows: Bond interviews in Early March (MMI; 2026 cycle); psychometric testing 7-12 Feb 2026; MMI invitations 21 Feb 2026; Tasmania in No interview.

Curriculum and teaching style

Both schools deliver a Integrated-style curriculum, so day-to-day study habits will feel similar across years 1-3.

Specifics: ~4.5-year accelerated Bachelor of Medical Studies (BMedSt) + Doctor of Medicine (MD) on a three-semester (Jan/May/Sep teaching) calendar — though inta 5-year undergraduate Bachelor of Medical Science / Doctor of Medicine (course code H3X; legacy MBBS M3N). Years 1-3 foundations and clinical skills at

Intake size: Bond — Up to ~180 places/year across two intakes (May + September), 80% undergraduate / 20% graduate. Full-fee only — does NOT participate in BMP.; Tasmania — Total not publicly aggregated; estimated ~110-135 domestic (school-leaver) + 25 graduate. TRTS 20 places; Medical Research Stream ~12-13 within graduate intake..

A larger cohort means more peer breadth; a smaller cohort means more tutor contact.

Post-interview offer rate

Bond: ~35% interview-to-offer. Tasmania: N/A — no interview.

Post-interview odds give you the clearest signal of how competitive each school is at the final stage — a school with a 60% post-interview success rate is structurally easier to convert than one at 25%, even if the interview thresholds look identical on paper.

What makes each distinctive

Bond: Bond is Australia's only private medical school with two intakes per year (May, September — NO February intake) on an accelerated calendar (~3 semesters/year, 14 semesters total, about 4 years 8 months end to end). No UCAT-ANZ or GAMSAT — Bond runs its own psychometric test (Clinical Personality + Emotional Intelligence).

All places are full-fee (no CSP, FEE-HELP eligible for domestic; no BMP). 2026 fees: $33,610/semester × 14 = ~$470,540 total program.

ELIGIBILITY: direct entry is limited to Australian citizens and permanent residents, Australian Humanitarian visa holders, and New Zealand CITIZENS (not NZ permanent residents) — it is NOT open to international students applying for a student visa, who must instead complete a prerequisite Bond degree and enter at Year 2.

Tasmania: Tasmania is the only medical school in the state. ATAR thresholds 99.95 (non-rural) / 99.45 (rural or Tasmanian) have held flat since at least 2022 — UCAT serves only as a tiebreaker. Aboriginal Entry Pathway (palawa) waives UCAT and the clinical aptitude test. Graduate Entry stream of 25 places/year includes the Medical Research Stream (~50% of grad places).

Which is right for you?

Start with the admission test: Bond needs Bond-Test, Tasmania needs UCAT-ANZ and GAMSAT. Preparing for one well beats splitting your time across two. Check your state of origin before you apply — Bond draws heavily on Queensland applicants and Tasmania on Tasmania, and an interstate application often faces a materially higher bar.

Your preference list should ultimately weight: which admission test you can realistically score well in, whether your state of origin gives you a bonus at either school, and where you'd actually want to live for four to six years.

Common questions

Bond uses Bond-Test. Tasmania uses UCAT-ANZ and GAMSAT. The test mismatch means you may need to prep two assessments simultaneously, or you can pick the school whose admission test you're stronger in. GAMSAT is graduate-only and sat in March/September; UCAT-ANZ is undergraduate-leaning and sat in July; some schools (notably Bond and JCU) run their own selection model with no national test.

School data reviewed by the NextGen MedPrep editorial team — last reviewed 25 August 2026.